Global Research Antibodies Market Analysis 2021-2028: Monoclonal Antibodies, Polyclonal Antibodies by Technology, Source, & Application

Dublin, Sept. 17, 2021 (GLOBE NEWSWIRE) -- The "Global Research Antibodies Market Analysis Report 2021-2028" report has been added to's offering.

The global research antibodies market size is expected to reach USD 5.9 billion by 2028 and is expected to expand at a CAGR of 6.4% from 2021 to 2028.

Major market drivers include a rise in R&D initiatives undertaken by biopharmaceutical and biotechnology companies and government bodies, an increase in neurobiology and stem cell research, availability of technologically advanced products, and strategic collaborations among various key players.

An increase in the usage of research antibodies to develop therapies for various chronic and infectious diseases, including COVID-19, is anticipated to boost the market growth during the forecast period. For instance, in June 2019, the Institute of Life Sciences (ILS, India) developed antibodies against chikungunya viral infection.

These antibody structures were developed to aid scientists in understanding various aspects of virus pathogenesis entailing further research on antiviral therapies. Growing government funds and initiatives for R&D are anticipated to fuel market growth during the forecast period in the Asia Pacific region. According to the 2018-2019 Australian Budget, approximately USD 94 million was estimated for four years for new industry collaborations, research as well as new biomedical and medical programs.

Additionally, a rise in funds invested by pharmaceutical and biotechnology companies to enhance proteomics and genomics research is expected to boost market growth.

Research Antibodies Market Report Highlights

  • In 2020, primary antibodies held a dominant share in terms of revenue in the product segment owing to greater specificity, therefore, leading to increase adoption in R&D activities
  • Monoclonal antibodies captured a substantial share in 2020, as they offer higher sensitivity for the detection of antigens and also showcase efficient staining properties for various applications
  • The neurobiology segment is expected to witness exponential growth over the forecast period owing to the increasing prevalence of diseases that have limited treatment options and the rise in R&D activities by biotech companies and academic institutes
  • Pharmaceutical and biotechnology companies were dominant in terms of revenue amongst all end-users in 2020, owing to the increased adoption of research antibodies in drug development and discovery
  • In 2020, North America accounted for the substantial revenue share which is attributable to the high presence of many biotechnologies as well as biopharmaceutical manufacturers, research academies, and laboratories

Market Dynamics

Market Driver Analysis

  • Increasing Investment In R&D
  • Growing Stem Cells And Neurobiology Research
  • Increase In Research Academies And Industry Collaborations
  • Rise In The Availability Of Technologically Advanced Products
  • Rise In Proteomics And Genomics Research

Market Restraint Analysis

  • Stringent Government Regulations
  • High Cost Of Research Antibodies

Market Opportunities Analysis

  • Increasing Opportunities In Various Emerging Markets
  • Growing Demand For Personalized Medicines
  • Rising Focus On Biomarker Discovery

Market Challenges Analysis

  • Quality Concerns Of Research Antibodies
  • Time And Cost Intensive Process Of Antibody Development
  • Pricing Pressures Faced By Major Market Players

Company Profiles

  • Abcam Plc
  • Bio-rad Laboratories
  • Becton Dickinson & Company
  • Merck Millipore
  • Lonza Group
  • Thermo Fisher Scientific, Inc
  • Cell Signalling Technology, Inc.
  • F.Hoffmann La Roche Ltd.
  • Agilent Technologies
  • Perkinelmer, Inc.

For more information about this report visit


Contact Data